BioLife Solutions to Present at the 2018 BIO International Convention
BioLife Solutions Inc. today announced that Michael Rice, CEO, and Roderick de Greef, CFO, will be attending and presenting at the 2018 BIO International Convention, June 4 – 7, 2018, at the Boston Convention and Exhibition Center. The corporate presentation is scheduled at 4:30PM on Monday, June 4th in theater 4. Investor and partner attendees interested to meet […]
SAVSU Technologies Announces Major evo.is® Cold Chain SaaS Update and New evo® Extreme Product Line for Shipping Cell Therapies
evo System Adopted by Leading Specialty Logistics Service Providers and Cell Therapy Manufacturers as Best Practice On May 2, 2018, our Joint Venture partner, SAVSU Technologies, the leading developer of smart precision shipping containers and cloud-based cold chain management SaaS solutions, announced two major upgrades to its industry best evo system; including enhanced software and shipping […]
BioLife Solutions Announces Preliminary First Quarter 2018 Revenue of $3.8 Million, up 61% Year-over-Year and 22% Sequentially 2018 Revenue Guidance Revised Upward
On April 2, 2018, BioLife Solutions Inc. (NASDAQ: BLFS) (“BioLife”), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media, announced preliminary revenue for the three months ended March 31, 2018. First quarter 2018 preliminary revenue from sales of BioLife’s proprietary CryoStor® and HypoThermosol® biopreservation media products reached $3.8 million, […]
BioLife Solutions and SAVSU Technologies to be Awarded Second Patent for Next Generation Cold Chain Technologies Designed for Cell and Gene Therapies
12 Additional Pending Patent Applications Submitted for evo® Smart Shippers, Liquid Nitrogen Dry Vapor Shippers and Cold Chain SaaS Application On March 26, 2018 BioLife Solutions Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media, and SAVSU Technologies, the leading developer of smart, […]
PDA Presentation: Cell Viability After Cryopreservation
On March 20, 2018 Dr. Brian Hawkins, Scientific Applications Director, will be presenting a poster entitled, “The prats and pitfalls of assessing cell viability after cryopreservation,” at the 2018 PDA Annual Meeting in Orlando, FL. The poster describes how common methods of determining cell viability under normal conditions are inconsistent and inaccurately represent cell health […]
BioLife Solutions CryoStor® Cell Freeze Media Highlighted in Mayo Clinic/MD Anderson Journal Article on Preservation of Patient-Derived Xenografts for Cancer Research
On March 13, 2018 BioLife Solutions Inc. (NASDAQ: BLFS) (“BioLife”), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media, announced that the performance of its proprietary, cGMP CryoStor cell freeze media was reported in the journal Laboratory Investigation. In multiple comparisons of preservation efficacy of patient-derived xenograft (PDX) tumors, […]
BioLife Solutions Announces Fourth Quarter and Full Year 2017 Financial Results
BioLife Solutions Announces Fourth Quarter and Full Year 2017 Financial Results Revenue Increased 39% for the Quarter and 34% for the Year Achieves Positive Cash Flow from Operations for the Year Reaffirms Guidance for 2018 Operating Profit On March 8, 2018 BioLife Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue […]
BioLife Solutions to Report Fourth Quarter and Full Year 2017 Financial Results and Provide Business Update on March 8, 2018
BioLife Solutions Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media (“BioLife” or the “Company”), announced that the Company’s fourth quarter and full year 2017 financial results will be released after market close on Thursday, March 8, 2018, and that the Company will host a […]
BioLife Solutions Executes OEM Agreement with MilliporeSigma
BioLife Solutions Executes OEM Agreement with MilliporeSigma Private Labeled CryoStor® Cell Freeze Media and HypoThermosol® Cell and Tissue Storage and Shipping Media Distributed to Worldwide Biotech Research Market On February 13, 2018 BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade biopreservation media (“BioLife” or the “Company”), announced that it has […]
Biopreservation Best Practices: A Cornerstone in the Supply Chain of Cell-based Therapies – MSC Model Case Study
Mesenchymal stromal cells (MSCs) are prime candidates for regenerative medicine and therapeutic applications due to both their potent immuno- modulatory function and a unique ability to proliferate and differentiate into a variety of cell lineages. However, the stresses incurred during biopreservation/stability intervals (non-frozen and cryopreserved), including transit to and from the clinic can render MSCs ineffective and potentially unsafe. […]